...
首页> 外文期刊>Journal of Medicinal Chemistry >Characterization of the drug binding specificity of rat liver fatty acid binding protein
【24h】

Characterization of the drug binding specificity of rat liver fatty acid binding protein

机译:大鼠肝脏脂肪酸结合蛋白的药物结合特异性的表征

获取原文
获取原文并翻译 | 示例

摘要

Liver-fatty acid binding protein (L-FABP) is found in high levels in enterocytes and is involved in the cytosolic solubilization of fatty acids during fat absorption. In the Current studies, the interaction of L-FABP with a range of lipophilic drugs has been evaluated to explore the potential for L-FABP to provide an analogous function during the absorption of lipophilic drugs. Binding affinity for L-FABP was assessed by displacement of a fluorescent marker, 1-anilinonaphthalene-8-sulfonic acid (ANS), and the binding site location was determined via nuclear magnetic resonance chemical shift perturbation studies. It was found that the majority of drugs bound to L-FABP at two sites, with the internal site generally having a higher affinity for the compounds tested. Furthermore, in contrast to the interaction of L-FABP with fatty acids, it was demonstrated that a terminal carboxylate is not required for specific binding of lipophilic drugs at the internal site of L-FABP.
机译:肝脂肪酸结合蛋白(L-FABP)在肠细胞中含量很高,并且在脂肪吸收过程中参与了脂肪酸的胞质溶解。在当前的研究中,已评估了L-FABP与一系列亲脂性药物的相互作用,以探索L-FABP在亲脂性药物吸收过程中提供类似功能的潜力。通过取代荧光标记物1-苯胺基萘-8-磺酸(ANS)评估对L-FABP的结合亲和力,并通过核磁共振化学位移扰动研究确定结合位点的位置。发现大多数药物在两个位点结合L-FABP,内部位点通常对测试的化合物具有更高的亲和力。此外,与L-FABP与脂肪酸的相互作用相反,已证明在L-FABP的内部位点上亲脂性药物的特异性结合不需要末端羧酸盐。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号